5th CONGRESS OF THE PSORIASIS INTERNATIONAL NETWORK 7 – 9 July 2016

P R E L I M I N A RY P R O G R A M M E & CALL FOR ABSTRACTS

5th CONGRESS OF THE PSORIASIS INTERNATIONAL NETWORK

PSORIASIS 2016 7-9 JULY 2016 PALAIS DES CONGRÈS – PARIS – FRANCE

Organised by PIN ​ Psoriasis International Network

PARIS, PALAIS DES CONGRÈS 7-9 JULY 2016

Scientific programme coordinated by SOLAPSO, Latin American Society of Psoriasis

www.pso2016.com

Follow us on

PSORIASIS 2016

Contents • . Welcome Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 • . Congress Organisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 • . Schedule at a glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 • . Psoriasis International Network . . . . . . . . . . . . . . . . . . . . . . . . . . 6 • . Abstracts submission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 • . Scientific Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 • . General Information & Conditions . . . . . . . . . . . . . . . . . . . . . . . . 14 • . Registration procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 • . Accommodation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 • . Sponsors Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . 20

Key Dates to remember • . Deadline for abstract submission for free communications and posters: February 12, 2016 • . Advance registration deadline: March 18, 2016 • . Deadline for hotel reservations: May 7, 2016 • . Opening on-site secretariat: July 7, 2016

Congress Office Scientific Secretariat, Registration, Accommodation, Exhibition, Sponsorship: PSORIASIS 2016 – MCI France 24 rue Chauchat - 75009 Paris – France Tel: 33 (0) 1 53 85 82 59 – Fax: 33 (0) 1 53 85 82 83 Email:

• For general information: pso@mci-group.com

• For registration and accommodation: psoREG@mci-group.com

• For exhibition and sponsorship: psoEXH@mci-group.com

• For abstract submission: psoABS@mci-group.com

Website: www.pso2016.com

2

PSORIASIS 2016

Welcome Address Dear Colleagues and Friends, On behalf of the Psoriasis International Network (PIN) of FRT-Fondation René Touraine, represented by professors Luigi Naldi and Thomas Luger, it is our great pleasure to cordially invite you to participate to PSORIASIS 2016 – 5th Congress of the Psoriasis international Network. SOLAPSO – Latin American Society of Psoriasis is one of the most dynamic regional psoriasis networks within PIN and was handed the responsibility of the scientific coordination of the congress by the assembly of PIN National Representatives.

This congress series is directly aimed to serve the needs of practicing dermatologists involved in psoriasis care across countries in outpatient services, hospital settings, and private practice, focusing on the patient management and therapeutic strategies with a special emphasis on the daily medical practice.

Therefore, we have invited keynote speakers throughout the world and from all fields of psoriasis research and care to report on their experiences and deliver insight into the latest results and clinical studies.

For 2016, in close collaboration with SOLAPSO, the 5th Congress of the Psoriasis International Network proposes a dynamic, interdisciplinary and interactive programme, including rheumatology points. A special attention will be given to psoriasis management in different scenarios, psoriatic arthritis and psychodermatology.

Furthermore, topics such as therapeutic targets in psoriasis, psoriasis in paediatrics, phototherapy, topical and systemic treatments and combined therapies, life quality and adherence to treatment, patient education, registries, pharmacoeconomics and psoriasis and internal medicine will also be addressed in workshops which allow you to directly interact with internationally experienced speakers.

Make sure that you don’t miss this unique opportunity to update your knowledge on psoriasis, and take also the advantage to enjoy Paris at this wonderful time of the year!

Sincerely,

Luigi NALDI

Thomas LUGER

Nélida RAIMONDO

President of PIN Scientific Committee Italy

President of FRT Scientific Board Germany

President of SOLAPSO Argentina

3

Congress Organisation

PSORIASIS 2016

Congress Organisation l Scientific

Coordination

SOLAPSO – Latin American Society of Psoriasis, represented by: Nélida RAIMONDO President, Argentina Cristina ECHEVERRIA Scientific Secretary, Argentina

l General

Coordination

PIN Scientific Committee of FRT – Fondation René Touraine, represented by: Luigi NALDI President PIN Scientific Committee, Italy Jo LAMBERT President-elect PIN Scientific Committee, Belgium Carle PAUL Past President PIN Scientific Committee, France Thomas LUGER President FRT Scientific Board, Germany Luis PUIG President-elect FRT Scientific Board, Spain Alexander Nast Member of PIN Scientific Committee, Germany

l Programme

Committee

Executive Committee of SOLAPSO www.solapso.org Members of the PIN Scientific Committee www.psoriasis-international.org/PIN‑Committee PIN National Representatives www.psoriasis-international.org/PIN‑National-Representatives

l Permanent

Organisation Secretariat

Psoriasis International Network – Fondation René Touraine, represented by: Cheila RAMALHO Project Officer, Psoriasis International Network Louis DUBERTRET President of the Board of Directors, FRT – Fondation René Touraine

4

Congress Organisation

PSORIASIS 2016

l Pin

Scientific Committee Members

PIN is steered by a Scientific Committee composed of 40 international opinion leaders that supervises the good development of the Psoriasis International Network.

Luigi NALDI, President, Italy Jo LAMBERT, President-elect, Belgium Carle PAUL, Past President, France Martine BAGOT, France Wolf-Henig BOEHNCKE, Switzerland José Manuel CARRASCOSA, Spain Romana CEOVIC, Croatia Elke DE JONG, The Netherlands Nejib DOSS, Tunisia Emad ELGAMAL, Egypt Ma. Lorna FREZ, Philippines Giampiero GIROLOMONI, Italy Cesar GONZALEZ, Colombia Alice GOTTLIEB, United States of America Christopher GRIFFITHS, United Kingdom

l PIN

Rolland GYULAI, Hungary Lars IVERSEN, Denmark Lajos KEMENY, Hungary Alur S. KUMAR, India Richard LANGLEY, Canada Mark LEBWOHL, United States of America Thomas LUGER, Germany Fatimata LY, Senegal Alan MENTER, United States of America Ulrich MROWIETZ, Germany Alexander NAST, Germany Frank NESTLE, United Kingdom Tamar NIJSTEN, The Netherlands Hugo SCHONENBERGER DE OLIVEIRA, Portugal

Jörg Christoph PRINZ, Germany Luis PUIG, Spain Nélida RAIMONDO, Argentina Kristian REICH, Germany Lone SKOV, Denmark Phyllis SPULS, The Netherlands Mona STAHLE, Sweden Georg STINGL, Austria Diamant THAÇI, Germany Skaidra VALIUKEVICIENE, Lithuania Peter VAN DE KERKHOF, The Netherlands Richard WARREN, United Kingdom Min ZHENG, China

National Representatives

Aomar AMMAR-KHODJA, Algeria Nélida RAIMONDO, Argentina Pablo FERNÁNDEZ-PEÑAS, Australia Patrick BRUNNER, Austria Uladzimir ADASKEVICH, Belarus Michel DE LA BRASSINNE, Belgium Félix ATADOKPEDE, Benin Juan Carlos DIEZ DE MEDINA, Bolivia Asja PROHIC, Bosnia and Herzegovina Luna AZULAY, Brazil Nikolai TSANKOV, Bulgaria Fatou BARRO TRAORE, Burkina Faso Christine MADENGUE, Cameroon Yves POULIN, Canada Claudia DE LA CRUZ, Chile Min ZHENG, China Chih-Hung LEE, Chinese Taipei Cesar GONZALEZ A., Colombia Laura ALVAREZ MORALES, Costa Rica Abdoulaye SANGHARE, Cote d’Ivoire Romana CEOVIC, Croatia Orestes BLANCO G., Cuba Jana HERCOGOVA, Czech Republic Robert GNIADECKI, Denmark Lars IVERSEN, Denmark Alexandra ESPINAL, Dominican Republic Emad ELGAMAL, Egypt Leana QUINTANILLA, El Salvador Jaime MARTINEZ LOPEZ, El Salvador Külli KINGO, Estonia Tarja MALKONEN, Finland Carle PAUL, France Sophie CONIQUET, Gabon

Nino CHIJAVADZE, Georgia Tsira LEONIDZE, Georgia Matthias AUGUSTIN, Germany Christina ANTONIOU, Greece Mohamed CISSE, Guinea Ligia RAMOS, Honduras Patricia MEJIAS, Honduras Rolland Gyulai, Hungary Jon Hjaltalin OLAFSSON, Iceland Alur S. KUMAR, India Benny E. WIRYADI, Indonesia Omid ZARGARI, Iran Brian KIRBY, Ireland Lev PAVLOVSKY, Israel Luigi NALDI, Italy Hidemi NAKAGAWA, Japan Laith AKKASH, Jordan Joo Heung Lee, Korea Nawaf AL MUTAIRI, Kuwait Andris RUBINS, Latvia Abdul Ghani KIBBI, Lebanon Gamal A. DUWEB, Libya Skaidra VALIUKEVICIENE, Lithuania Emilija MANASIEVSKA, Macedonia Azura Mohd AFFANDI, Malaysia Ousmane FAYE, Mali Michael BOFFA, Malta Mamadou BALL, Mauritania Gladys LEON DORANTES, Mexico Boris NEDELCIUC, Moldova Fatima Zahra MERNISSI, Morocco Phyllis I. SPULS, Netherlands Jorge NEIRA, Nicaragua

Ousmane KONATE, Niger Abel Nze ONUNU, Nigeria Riad MASHAL, Palestine Giuliana CASTRO, Peru Maria Lorna FREZ, Philippines Jacek SZEPIETOWSKI, Poland Hugo OLIVEIRA, Portugal Hassan RIAD, Qatar George-Sorin TIPLICA, Romania Nikolay POTEKAEV, Russia Serge SKREK, Russia Iqbal A. BUKHARI, Saudi Arabia Fatimata LY, Senegal Ljiljana MEDENICA, Serbia Colin THENG, Singapore Slavomir URBANCEK, Slovakia Tomaz LUNDER, Slovenia Luis PUIG, Spain Mona STAHLE, Sweden Nikhil YAWALKAR, Switzerland Fouz HASSAN, Syria Pravit ASAWANONDA, Thailand Vincent Pitche, Togo Nejib DOSS, Tunisia Mehmet Ali GURER, Turkey Fayza AL ALI, United Arab Emirates Christopher GRIFFITHS, United Kingdom Mark LEBWOHL, United States of America Oleksandr LITUS, Ukraine Carlos CARMONA, Uruguay Erika PAEZ, Venezuela Alfredo LANDER, Venezuela Aiman ALSHAMI, Yemen

5

PSORIASIS 2016

WHO ARE WE? • A network of 4700 dermatologists in 100 countries and 40 national and international patient organisations involved in psoriasis management • Connecting 285 psoriasis centres in 60 countries • Collaborating with regional psoriasis networks in Europe, Latin America, Arab countries, West-Africa and Asia • Steered by an international Scientific Committee, composed of 40 opinion leaders in the field of psoriasis • 100 PIN National Representatives as relays for the network’s projects, surveys and events at the national level

WHAT DO WE DO? • Organisation of the international congress

on psoriasis focusing on the daily medical practice (PSO 2007, PSO 2010, PSO 2013, PSO 2016) • Organisation of educational symposia in international meetings • Promoting the development of national and regional networks on psoriasis • Fostering the development of dedicated psoriasis outpatient consultations • Fostering international collaborations and clinical and therapeutic research in the field of psoriasis • 2012 Worldwide Survey on the Use of Methotrexate in the Treatment of Psoriasis - results published in JEADV • World Interactive Map Directory of Psoriasis Medical Resources for Patients available on PIN’s website

Coordinators of the Psoriasis International Network Scientific Committee

COME AND JOIN US! MORE INFORMATION AVAILABLE AT: www.psoriasis-international.org From left to right: President: Luigi Naldi (Italy) President-elect: Jo Lambert (Belgium) Past President: Carle Paul (France) President FRT Scientific Board: Thomas Luger (Germany) President-elect FRT Scientific Board: Luis Puig (Spain)

6

7

PSORIASIS 2016

Schedule at a glance THURSDAY, JULY 7

FRIDAY, JULY 8 –

–

Workshop 4 9:00

9:00

REGISTRATION

Round Table

11:00

Workshop 5

Workshop 6

Psoriasis Non-biological Controversy II: systemic Related comorbidities treatments today: need for repositioning?

10:00

10:00

–

Therapeutic targets in psoriasis

–

–

Psoriasis by non‑dermatologists: what you have to know

Short Presentations

SATURDAY, JULY 9 –

Workshop 10 Workshop 11 Workshop 12 9:00

Therapeutic optimization in psoriasis

Biologics today and in the future

Phototherapy

–

10:00

Break and Poster Viewing –

Break and Poster Viewing –

Session Late Breaking News

11:00

11:00

PLENARY SESSION 2 –

–

12:00

12:00

Psoriasis beyond T cells.

Searching for other actors (Keratinocytes, mast cells, etc.)

PLENARY SESSION 3 –

“Patient-oriented therapies” (personalized/custom-made)

12:00

Satellite Symposia –

–

13:00

13:00

–

Ice-Breaker in the Exhibition Area

–

–

Satellite Symposia/ Lunch Break and Poster Viewing

14:00

14:00

13:00

–

14:00

Workshop 13 Workshop 14 Workshop 15

Break and Poster Viewing –

15:00

–

PLENARY SESSION 1 Psoriasis as a Systemic Inflammatory disease: Genetic and immunologic background

–

–

Workshop 1

Workshop 2

Workshop 3

Internal Medecine and Psoriasis

Psoriasis Controversy I: Biosimilars

Treatments in Psoriatic Arthritis in adults and children

18:00

(IFPA, EUROPSO, LATINAPSO, PSORASIA)

15:00

Registries (regional differences, uncovered needs, communication networks, access to patients data)

Life quality, adherence to treatment and access to treatment

–

Break and Poster Viewing 16:00

–

17:00

17:00

CLOSING PLENARY SESSION Satellite Symposia –

–

18:00

18:00

Patient Associations Meeting

–

Patients follow up with biologics and other treatments (How often?

What to do?)

–

–

–

19:00

Workshop 9

Psoriasis in children

Break and Poster Viewing

Break and Poster Viewing –

–

Workshop 8

Psoriasis: Topical treatments management in today different moments (children, seniors, pregnancy, breast feeding)

16:00

16:00

17:00

–

Workshop 7 15:00

Satellite Symposia/ Lunch Break and Poster Viewing

19:00

PIN National Representatives Meeting

–

There will be in each session time for questions and answers.

Looking into the future

PSORIASIS 2016

Abstracts submission The DEADLINE for ABSTRACTS submission is: February 12, 2016.

Please go to the website to read the guidelines and submit your abstract:

www.pso2016.com All abstracts must be written in English.

Selected abstracts will be presented as posters and the best scored posters will be presented during the workshop sessions.

Submission topics: 1.

Scoring and monitoring the severity of the disease

2.

Psoriasis in children and pregnancy

3.

Psoriasis Arthritis

4.

Comorbidities in Psoriasis

5.

Psychological/Social impact of psoriasis

6.

Psoriasis – pathogenesis

7.

Clinical guidelines and recommendations for psoriasis treatment

8.

Health economics of psoriasis

9.

Patient education

10. Clinical trials in psoriasis 11. Epidemiology 12. Clinics in psoriasis 13. Therapeutics

Remember that ONLY electronically submitted abstracts will be considered.

8

SCIENTIFIC PROGRAMME

PSORIASIS 2016

Day 1: Thursday, July 7, 2016 08:30-10:00

Registration 10:00-11:30 Round Table

“Psoriasis by non-dermatologists: what you should know” Chair: Luigi Naldi (Italy)

1. Presentation title to be confirmed – Carolina Cortéz Correa (Colombia)

2. The importance of screening for comorbidities – Gladys Leon Dorantes (Mexico)

3. Itch in psoriasis and its negative impact on patients’ psyche – Jacek Szepietowski (Poland)

4. Screening campaigns in the general community – Minerva Gomez (Mexico)

5. Clinical manifestations and convential therapy for psoriasis – Emad Elgamal (Egypt)

Short Presentations Session

“Late Breaking News“ Chairs: Luis Puig (Spain), Jo Lambert (Belgium) Speakers: to be confirmed at a later stage 13:00-14:00

Ice-Breaker in the Exhibition Area 14:00-16:00

Plenary Session 1 “Psoriasis as a Systemic Inflammatory disease: Genetic and immunologic background” Chairs: Lone Skov (Denmark), Maria Lorna Frez (Philippines), Peter van de Kerkhov (Netherlands)

1. Microbiome and Psoriasis: up to date – Thomas Luger (Germany)

2. The relationship between Psoriasis and the autoinflammatory diseases – HJ Song (Korea)

3. New insights in Psoriasis genetics and epigenetics – Mario Bittar (Argentina)

4. Cytokine networks in Psoriasis and its comorbidities – Stefan Beissert (Germany)

5. Psoriasis and cardiovascular disease: do they share the same inflammatory pathways? – Nehal Mehta (USA)

9

SCIENTIFIC PROGRAMME

PSORIASIS 2016

16:00-16:30 BREAK 16:30-18:00

Workshops W1

Internal Medicine and Psoriasis

Chairs: Carolina Velasquez (Colombia), Mehmet Ali Gürer (Turkey)

1. Psoriasis and Cancer: is everything related to therapies? – Peter van de Kerkhof (Netherlands)

2. Ulcerative colitis, Crohn and Psoriasis: common physiopathological pathways?

– Nancy Podswa (Mexico)

3. Metabolic syndrome and psoriasis – Akihiko Asahina (Japan)

4. Psychological comorbidities – Paolo Gisondi (Italy)

W2

Psoriasis Controversy I: Biosimilars

Moderators: Diamant Thaçi (Germany), Claudia de la Cruz (Chile) Speakers: Kim Papp (Canada) & Alan Menter (USA) W3

Treatments in Psoriatic Arthritis in adults and children

Chairs: Irene Araya (Chile), Nora Poggio (Argentina), Ignacio Dei Cas (Argentina)

1. Influence of cutaneous involvement in deciding how to treat psoriatic arthritis – Axel Villani (France)

2. State of the art in ultrasound evaluation of Ps and PsA – Carlos Pineda (Mexico)

3. Biologics in the treatment of psoriatic arthritis in children Present and future – Frank Behrens (Switzerland)

4. Treatment of psoriatic arthritis: traditional DMARDs and new therapies, approaches and recommendations? – Kurt de Vlam (Belgium)

18:00-19:30

Patient Associations Meeting

(IFPA, EUROPSO, LATINAPSO, PSORASIA)

10

SCIENTIFIC PROGRAMME

PSORIASIS 2016

Day 2: Friday, July 8, 2016 08:30-10:00

Workshops W4

Therapeutic targets in psoriasis

Chairs: Graciela Pellerano (Argentina), Thomas Luger (Germany)

1. New topical targets – Matias Maskin (Argentina)

2. The role of genetics in treatment stratification – Speaker to be confirmed

3. Are PPARs a promising target to treat psoriasis? – Ricardo Romiti (Brazil)

4. Small molecules: JAK inhibitors, Phosphodiesterase inhibitors and A3 adenosine receptor agonists – Ulrich Mrowietz (Germany)

5. Anti-IL 17 and Anti- IL 23: where are we and where do we go? – Kenneth Gordon (USA)

P soriasis Controversy II: Related comorbidities – Is there now enough evidence that controlling psoriasis really decreases cardiovascular risk?

W5

Chairs: Fernando Stengel (Argentina), Marc Bourcier (Canada)

1. Yes – Jashin Wu (USA)

2. No – Tamar Nijsten (Netherlands)

W6

Non-biological systemic treatments today: need for repositioning?

Chairs: Skaidra Valiukeviciene (Lithuania), Tatiana Riveros (Chile), Nora Kogan (Argentina)

1. Fumarates PML – how to monitor and can it still be considered as safe as before? – Sandra Philipp (Germany)

2. Methotrexate - s.c. versus oral, monitoring of the liver toxicity – Rolland Gyulai (Hungary)

3. Cyclosporine – use it in case of preexising arterial hypertension?

Relevant changes in kidney function, what is normal, when to stop? – Fernando Valenzuela (Chile)

4. New and upcoming small molecules – Richard Langley (Canada)

10:00-10:30 BREAK

11

SCIENTIFIC PROGRAMME

PSORIASIS 2016

10:30-12:30

Plenary Session 2 Psoriasis beyond T cells. Searching for other actors (Keratinocytes, mast cells, etc) Chairs: Min Zheng (China), Georg Stingl (Austria), Peter van de Kerkhof (Netherlands)

1. Keratinocytes and antimicrobial peptides in psoriasis – Antonio Constanzo (Italy)

2. Mast cells and neutrophils in psoriasis – Kristian Reich (Germany)

3. Dermal and epidermal microenvironment in psoriasis plaque – Jörg Christoph Prinz (Germany)

4. Dendritic cells and the narrow line between tolerance and effective immunogenic response in psoriasis – Roberto Lande (Italy)

12:00-14:30 Break 14:30-16:00

Workshops W7

Psoriasis: management in different moments (children, seniors, pregnancy, breast feeding)

Chairs: Romana Ceovic (Croatia), Fatimata Ly (Senegal), Hidemi Nakagawa (Japan)

1. My patient is on systemic treatment and is pregnant! What do I have to do? – Luna Azulay (Brazil)

2. Psoriasis treatment in the elderly: what about frailty and multimorbidity? – Yoshinori Umezawa (Japan)

3. Children systemic therapies today: from the evidence to the clinical practice – Marieke Seyger (Netherlands)

4. Recommendations for patients under systemic treatment in case of traveling and surgery – Alex Abarca Duran (Costa Rica)

W8

Topical treatments today

Chairs: Leana Quintanilla (El Savador), Riad Mashal (Palestine), Asja Prohic (Bosnia Herzegovina)

1. Adherence: the first goal in topical treatments – Norito Katoh (Japan)

2. Which is the role of topical therapy in nail psoriasis? – Speaker to be confirmed

3. Corticosteroids with and without vitamin D. Still the first choice? – Lars Iversen (Denmark)

4. Emerging topical drugs – Luis Mazzuoccolo (Argentina)

12

SCIENTIFIC PROGRAMME

PSORIASIS 2016

W9

Patients follow up with biologics and other treatments (How often? What to do?)

Chairs: Mario Amaya (Mexico), Pablo Gonzalez (Argentina), Tomaz Lunder (Slovenia)

1. Classical; a. Methotrexate, b. Cyclosporine, c. Acitretin – Cesar Gonzalez (Colombia)

2. Biologicals inhibiting TNF, IL 12/23 and IL 17: What to use? How to choose? – Hervé Bachelez (France)

3. Small molecules: a.Apremilast, b.Tofacitinib – Craig Leonardi (USA)

4. Combination therapies – Phyllis Spuls (Netherlands)

16:00-16:30 Break 18:00-19:30

Pin National Representatives Meeting

Day 3: Saturday, July 9, 2016 08:30-10:00

Workshops W10

Therapeutic optimization in psoriasis

Chairs: Guadalupe Villanueva (Mexico), Juan Raul Castro Ayarza (Colombia), Wolf‑Henning Boehncke (Switzerland)

1. Treatment goals and transition therapies: from guidelines to the real world – Cristina Echeverria (Argentina)

2. Treat to target in psoriasis and psoriatic arthritis – Alexa Kimball (USA)

3. Immunogenicity impact in treatment choice and transition therapies – Gertjan Wolbink (Netherlands)

4. Optimization-Combination treatment – Phyllis Spuls (Netherlands)

W11

Biologics today and in the future

Chairs: Angela Londono (Colombia), Hugo Schönenberger de Oliveira (Portugal), Esteban Dauden (Spain)

1. The impact of biologics in psoriasis comorbidities – Yves Poulin (Canada)

2. New molecules in the pipeline – Kim Papp (Canada)

3. Health economics and biologics prescription: worldwide differences – Matthias Augustin (Germany)

13

PSORIASIS 2016

W12

Phototherapy

Chairs: Lajos Kemeny (Hungary), Débora Kaplan (Argentina), George-Sorin Tiplica (Romania)

1. The relation between phototherapy and skin cancer: how can we minimize the risks? – Hernan Correa (Chile)

2. Targeted UVB phototherapy: indications and limitations – Alex Anstey (UK)

3. Home phototherapy: when and how? Is it safe? – Speaker to be confirmed

4. Phototherapy in pediatric patients – Joanna Narbutt (Poland)

10:00-10:30 BREAK 10:30-12:30

Plenary Session 3 “Patient-oriented therapies” (personalized/custom-made) Chairs: Edgardo Chouela (Argentina), AJ Kanwar (India), Lluis Puig (Spain)

1. Genetic background and treatment response: personalized therapies? – Georg Stingl (Austria)

2. Phenotyping in psoriasis: a major clinical research project for PIN – Louis Dubertret (France)

3. Pharmacogenetics and pharmacogenomics in psoriasis: today and in the future – Warren Richard (UK)

4. The influence of health resources in the access to drugs: differences around the world – José Manuel Carrascosa (Spain)

5. Therapeutic patient education: added value in psoriasis? – Jo Lambert (Belgium)

14:00-15:30

Workshops W13

Psoriasis in children

Chairs: Carla Castro (Argentina), Laura Alvarez Morales (Costa Rica), Paula Luna (Argentina)

1. Epidemiology, diagnosis and prognosis – Vincenz Oji (Germany)

2. Topical and systemic therapies for children today – Emmanuel Mahé (France)

3. How to balance long-term efficiency and safety? – Anna Belloni (Italy)

4. Comorbidities and beyond – Speaker to be confirmed

14

PSORIASIS 2016

W14

R egistries (regional differences, uncovered needs, communication networks, access to patients data)

Chairs: Luigi Naldi (Italy), Rolland Gyulai (Hungary), Nejib Doss (Tunisia)

1. Goals and limitations in psoriasis registries, regional differences and regulatory issues – Edgardo Chouela (Argentina)

2. The Biobadaderm registry experience: Spain leading the way – Ignacio Garcia Doval (Spain)

3. Well refined clinical questions matter: the case of the Danish registry – Speaker to be confirmed

4. How to interpret registry data? How does registry data match with RCT data and results from meta-analysis? – Alexander Nast (Germany)

W15

Life quality, adherence and access to treatment

Chairs: Martine Bagot (France), Simon Gusis (Argentina)

1. Access to medications in developing countries: itolizumab, biosimilars and copies – Alur s. Kumar (India)

2. Coping strategies and the role of patient social network: tools to decrease life quality impact? – Speaker to be confirmed

3. Could early high effective therapies decrease the burden of the psoriatic disease? – Speaker to be confirmed

4. Whole person care, quality of life and health care systems – Matthias Augustin (Germany)

5. The role of physicians, family and social environment to increase adherence: creating new strategies – Christine Bundy (UK)

15:30-16:00 BREAK 16:00-18:00

Closing Plenary Session “Looking into the future” Chairs: Nélinda Raimondo (Argentina), Frank Behrens (Switzerland), Joo-Heung Lee (Korea)

1. Research: Frank Nestlé (UK) – James Krueger (USA)

2. Therapeutics: Lluis Puig (Spain) – Carle Paul (France)

15

General information & Conditions

PSORIASIS 2016

General information & Conditions l Welcome

to Paris!

Palais des Congrès

Roissy Charles de Gaulle Gare St Lazare

Gare du Nord Gare de l'Est

Gare Montparnasse

Gare d’Austerlitz

Gare de Lyon

Orly

l Venue

and Dates

The 5th International Congress of Psoriasis will be held from Thursday 7 to Sunday 9 July 2016 in the Palais des Congrès, in Paris.

Paris can easily be reached by plane, train or car, as it is located crossroad of Europe. It is served by two international airports and a very convenient railway system. The shuttle buses from Charles de Gaulle or Orly airports arrive down town.

The Palais des Congrès is easily accessible: by car (Parking Porte Maillot under the Convention Centre), by local city bus (lines 82 - 73 - 43 - 244 PC) or by metro (line 1) or RER (Paris Suburban Express Metropolitan Network, line C). The station is called “Porte Maillot”.

l Official

language

Organized by an International Scientific Society, all presentations will be given in English.

16

General information

PSORIASIS 2016

l Congress

office

Before and after the meeting: PSORIASIS 2016 - MCI France 24 rue Chauchat – 75009 Paris – France Tel: 33(0) 1 53 85 82 59 – Fax: 33 (0) 1 53 85 82 83 E-mail: pso@mci-group.com – web: www.pso2016.com On-site Secretariat: (Tentative Opening hours) Thursday, July 7, 2016: 08:30 am – 06:00 pm Friday, July 8, 2016:

07:30 am – 06:00 pm

Saturday, July 9, 2016: 08:00 am – 06:00 pm The Congress documentation will be available there for pre-registered delegates and for anyone wishing to register on site.

l Badges A name badge will be provided with your registration documents on site (and not mailed out prior to the congress).

l Climate

and clothing

The weather in Paris in July is usually hot and sunny with daily temperatures ranging from 20°C to 25°. Night temperatures are usually mild.

l cme

credits

Continuing Medical Education credits will be offered by Medical Academies and Scientific Societies from all over the world. Participants may register for CME credits in their own countries.

Certificate of attendance will be delivered on site. More information will be posted on the Congress website in due time.

l Currency

exchange

ALL RATES given in the programme are in EUROS: €

l Electricity Electricity used in France is 220 Volts; its frequency is 50 Hz and the plugs have two male contact points. Plan to bring a transformer for your electrical or electronic equipment using different voltage.

17

General information

PSORIASIS 2016

l Exhibition

& Sponsorship

A scientific and technical exhibition will be open on Thursday afternoon, Friday and Saturday all day to pharmaceutical companies, manufacturers of materials and equipment and scientific publishers. It will be held in the Congress Venue.

As a pharmaceutical company or manufacturer, you may want to sponsor a session within the core programme or organize a satellite meeting.

For exhibit or sponsorship, you can contact any time the Congress Office: psoEXH@mci-group.comp

l Insurance

& Liability

The Organizers will accept no liability for personal injuries sustained by or for loss or damage to property belonging to Congress participants, either during or as a result of the Congress or during all events.

Participants are strongly recommended to seek insurance coverage for health and accident, lost luggage and trip cancellation.

l Lunches

& Break

Lunches are NOT included in the registration fees but sandwiches and snacks can be purchased at all times within the premises of the Palais des Congrès.

l Telephones For international calls to France, dial the international code followed by 33 and the correspondent’s number without the “0”.

18

Registration

PSORIASIS 2016

Registration procedure All participants must be registered and are urged to register in advance. You can register on line on a secure server in paying with your credit card or bank transfer via the Congress website: www.pso2016.com (and follow the instructions).

Registration per phone will not be processed. Registrants will receive confirmation by way of an invoice and acknowledgement letter which will be mailed and which will recall all the information given on the registration form, including the amount of Value Added Tax (VAT) paid and all other requests. This confirmation letter should be presented upon arrival at the Pre-registration Counter.

Until March 18, 2016 After March 18, 2016

On-Site

Participant 580 € 650 € 730 € Student*

220 € 220 € 220€

Patient Association member** Non-Dermatologist

1-Day pass for Thursday, July 7 only

free

free

free

100 € 100 € 100 €

All indicate rates above include a VAT of 20% at current rate at the day of printing. * Please provide certificate ** Please provide a copy of a valid membership card. Only members of patient associations affiliated with Psoriasis International Network (PIN) can benefit from this free rate. For information on how your patient association can become member of PIN, please contact weboffice@psoriasis-international.org.

l Delegates’

registration fees include:

• Admission to all congress sessions, poster area and technical exhibition • Congress documents (final programme, abstracts book or CD/Rom, congress bag)

l Terms

of payment

• The “Fondation René Touraine pour la Dermatologie”, (Hôpital Saint Louis, 1, avenue Claude Vellefaux, 75010 Paris) has given mandate to MCI for the organization of the 5th INTERNATIONAL CONGRESS ON PSORIASIS 2016 and therefore to act and receive the fees on its behalf.

• Payment must be sent to the Congress Office in EUROS (€) – by Credit card : VISA, EURO/MASTER CARD or AMEX only (NO other cards accepted) or – by bank transfer to the order of MCI France to CREDIT LYONNAIS – Agency: Le Crédit Lyonnais – Direction Entreprise 19 boulevard des Italiens – 75002 Paris – France Bank code : 30002 – Sort code : 05666 – account : 000 006 0133 P – Key : 15 BIC : CRLYFRPPXXX – IBAN : FR91 3000 2056 6600 0006 0133 P15 Copy of the bank transfer must be attached to the registration form. Do NOT forget to give the name of the congress and of the person you are paying for, on the bank transfer order.

19

Registration

PSORIASIS 2016

l Name

changes / Modifications

A processing fee of 30 € will be charged for changes in registration except for name substitutions which will be treated as new registrations.

l Cancellation

policy for individual registration & Reservations All cancellations must be notified in writing (by mail or e-mail) to the Congress Office according to the following conditions and reimbursement will be processed AFTER the Congress. Requests for refunds made after September 1, 2016 will not be considered: • Up to March 18, 2016: 100 Euros will be withheld for administrative fee, • Cancellations between March 19 and May 1, 2016: reimbursement of 50% of the fees paid, • After May 1, 2016: no refund.

l Visa Every person entering France should be in possession of a valid passport and/or identification card (except for members of the Euro zone). Some countries require a visa. Please contact the nearest French Embassy or Consulate to your home for further information.

You can get detailed information from the web site of French Ministry of Foreign Affairs at: http://www.diplomatie.gouv.fr/en/coming-to-france/getting-a-visa/ The Congress Office can assist you with an official invitation letter for visa application purposes.

Please complete the form on the congress website www.pso2016.com (registration section) in order to submit your request.

20

ACCOMMODATION

PSORIASIS 2016

21

Accommodation Hotel rooms at special Congress rates are being held for congress participants and their families in various hotels of different categories in the vicinity of the Congress Venue. But there will be no shuttle services provided by the congress between the congress hotels and the Palais des Congrès.

To make a reservation, visit the Congress website: www.pso2016.com A PAYMENT of the FULL STAY will be requested for all hotel reservations. It will be automatically deducted from the total amount of your hotel bill when leaving.

Room reservation will be made upon availability on a first come, first served basis.

l Room

rates

All rates are indicated in euros, per night and per room. Reservations must be made through the Congress Office to guarantee the indicated rates negotiated for the Congress. Unless otherwise indicated, most of the rates do not include breakfast.

PEARLS is an educational programme supported by Janssen, which focuses on improving understanding in psoriatic disease.

PEARLS aims to enhance care for patients by keeping healthcare professionals informed about the latest insights and advances in psoriasis, psoriatic arthritis and other related conditions such as inflammatory bowel disease (IBD). The PEARLS programme: • Raises awareness of comorbidities associated with psoriatic disease • Provides expert insights into optimal management of patients suffering from psoriasis and related comorbidities • Includes a wide variety of educational resources relating to psoriasis and psoriatic arthritis • Hosts a range of events from intimate masterclass meetings to large standalone events

With the support of Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA.

Janssen Pharmaceutica NV ©2015_Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340, Beerse, Belgium. PHEM/IMM/1115/0001.

Look out for our satellite symposium at PSORIASIS 2016!

Date: Friday 8th July Time: 12.30 to 14.00

ACCOMMODATION

PSORIASIS 2016

22

Do not forget: • If you decide to postpone your stay at the last minute, the rooms will be kept by the hotels according to the amount of the payment received.

• If you are delayed, think of informing the hotel.

• No reservation will be made without the requested deposit.

l List

of hotels

Stars Hotels Type of room

Single room Double room rate Breakfast rates Breakfast included included

Address

4 Hyatt Regency Paris Étoile Queen 222,48 € 254,96 €

3 place du Général Koenig 75850 PARIS CEDEX

4 Hotel De Banville Classique 369,00 € 399,00 €

166 Boulevard Berthier 75017 Paris

3 BW Star Champs Elysées Standard 195,65 € 211,30 €

18 rue de l’Arc de Triomphe 75017 PARIS

3 Le Magellan

17-19 rue Jean-Baptiste Dumas 75017 Paris

l Cancellation

Standard single with shower

140,00 € 170,00 €

conditions for hotel reservations

All cancellations must be notified in writing (by mail, fax or email) to the Congress Office according to the following conditions: • Cancellations before April 1st: 50% of the payment will be withheld • After April 2, 2016: no refund.

PSORIASIS 2016

Sponsors Acknowledgements The Organising Committee would like to thank the following companies for their support.

Platinum Corporate Partner

Silver Corporate Partner

Bronze Corporate Partner National Psoriasis Foundation Sandoz Biopharmaceuticals

Industry Satellite Symposia AbbVie Satellite Symposium (date and time to be announced) An educational symposium organised as part of the PEARLS programme and supported by Janssen Pharmaceutica N.V. Friday July 8, 2016 from 12.30 pm to 02.00 pm Satellite Symposium Lilly Friday July 8, 2016 from 12.30 pm to 02.00 pm

Check the congress website for the updated list of Industry Satellite Symposia!

CONGRESS OFFICE PSORIASIS 2016 - MCI France 24 rue Chauchat - 75009 Paris – France Tel: 33 (0) 1 53 85 82 59 – Fax: 33.(0) 1 53 85 82 83 Email: pso@mci-group.com – website: www.pso2016.com

24